In the News | Friends of Cancer Research

You are here

In the News

The New York Times- A Primer on the Details of Health Care Reform

By ROBERT PEAR and DAVID M. HERSZENHORN, With the debate over the future of health care now shifted from Capitol Hill to town halls, supporters and critics of the Democrats’ legislative proposals are

 polishing their sound bites and sharpening their attack lines. 

New York Times- To Fight Cancer, Know the Enemy

By JAMES D. WATSON, The National Cancer Institute, which has overseen American efforts on researching and combating cancers since 1971, should take on an ambitious new goal for the next decade: the development of new drugs that will provide lifelong cures for many,

New York Times- Lack of Study Volunteers Hobbles Cancer Fight

By Gina Kolata, Not long ago, at a meeting of an advisory group established by Congress to monitor the war on cancer, participants were asked how to speed progress.

AP- Dodd has prostate cancer

By LAURIE KELLMAN, Sen. Christopher Dodd, D-Conn., has been diagnosed with an early stage of prostate cancer and intends to have surgery early in August, his office said Friday.

Dodd intends to be back at work when Congress reconvenes in September, according to an e-mail his office circulated to fellow senators. The AP obtained a copy. 

Aides also said the diagnosis would not affect Dodd's plans to seek a sixth term in 2010.

Dodd planned to announce the diagnosis at a news conference in Hartford, Conn., Friday afternoon.

Washington Post- Baucus Touts Lower Cost of Compromise Health-Care Bill

By Shailagh Murray and Paul Kane, As the House moved closer to agreement on its health bill, Senate Finance Chairman Max Baucus announced that a draft of the reform package he is negotiating with three Republican senators would come with a lower-than-expected price tag, less than $900 billion over 10 years.

Washington Post- Key Lawmakers Restart Health-Care Talks

By Paul Kane, Key congressional negotiators resumed talks Monday evening on the emerging health-care legislation, scrambling to strike separate deals in House and Senate committees that would give momentum to the stalled reform effort.

With lawmakers just days away from a five-week break, members of the Senate Finance Committee and the House Energy and Commerce Committee huddled on opposite ends of the Capitol, trying to come to terms with the scope of the legislation and how to pay for revamping the health-care industry.

NPR- Health Effects Of Comparing Care: No Easy Answers

by Joanne Silberner, The Obama administration and Congress are moving forward with plans to evaluate the strengths and weaknesses of the various medical treatments for common health conditions, despite concerns of some lawmakers and the drug and device industry that it will lead to ratio.

But how the government uses this comparative effectiveness research and how it might benefit — or complicate — the decision-making of average people and their doctors are also matters of some debate.

Newsweek- ‘The Cause of My Life’... Inside the fight for universal health care.

By Edward M. Kennedy, In 1964, I was flying with several companions to the Massachusetts Democratic Convention when our small plane crashed and burned short of the runway. My friend and colleague in the Senate, Birch Bayh, risked his life to pull me from the wreckage. Our pilot, Edwin Zimny, and my administrative assistant, Ed Moss, didn't survive. With crushed vertebrae, broken ribs, and a collapsed lung, I spent months in New England Baptist Hospital in Boston.

DOW JONES NEWSWIRES - US Senate Panel Approves 12-Year Biologic Drug Exclusivity

By Patrick Yoest, The Senate Health, Education, Labor and Pensions Committee approved an amendment late Monday that would protect makers of biologic drugs from competition from generic drug manufacturers for 12 years.

The drugs -- which are manufactured by living cells -- represent a growing segment of the pharmaceuticals industry. The committee vote on the amendment, sponsored by Sens. Orrin Hatch, R-Utah, and Mike Enzi, R-Wyo., gives the biotechnology industry a major victory.

NY Times- Health Reform, a Cancer Offers an Acid Test

By DAVID LEONHARDT, It’s become popular to pick your own personal litmus testfor health care reform.For some liberals, reform will be a success only if it includes a newgovernment-run insurance plan to compete with private insurers. Formany conservatives, a bill must exclude such a public plan. Forothers, the crucial issue is how much money Congress spends coveringthe uninsured.My litmus test is different. It’s the prostate cancer test.